Literature DB >> 1353030

Non-alpha 2-adrenoceptor idazoxan binding sites; a new target for drug development.

A T Kilpatrick1, C C Brown, A C Mackinnon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1353030     DOI： 10.1042/bst0200113

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  4 in total

1.  Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.

Authors:  C A Brown; A C Loweth; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

2.  Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.

Authors:  G Olmos; A M Gabilondo; A Miralles; P V Escriba; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

3.  The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.

Authors:  R Alemany; G Olmos; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

4.  Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.

Authors:  C A Brown; S L Chan; M R Stillings; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.